Gender‐based outcomes of impeller pumps percutaneous ventricular assist devices
Background There is paucity of data focusing on females' outcomes after the use of impeller pumps percutaneous ventricular assist devices (IPVADs). Methods Patients who received IPVADs during the period of October 1st, 2015‐December 31, 2017, were identified from the United States National Read...
Gespeichert in:
Veröffentlicht in: | Catheterization and cardiovascular interventions 2021-04, Vol.97 (5), p.E627-E635 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
There is paucity of data focusing on females' outcomes after the use of impeller pumps percutaneous ventricular assist devices (IPVADs).
Methods
Patients who received IPVADs during the period of October 1st, 2015‐December 31, 2017, were identified from the United States National Readmission Database. A 1:1 propensity score matching was used to compare the outcomes between females and males.
Results
A total of 19,278 (Female = 5,456; Male = 13,822) patients were included in the current analysis. After propensity score matching and among all‐comers who were treated with IPVADs, females had higher in‐hospital major adverse events (MAEs) (38 vs. 32.6%, p |
---|---|
ISSN: | 1522-1946 1522-726X |
DOI: | 10.1002/ccd.29222 |